Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Preoperative Imaging in Patients With Small Bowel Neuroendocrine Tumors
This clinical trial update reports on preoperative imaging in patients with small bowel neuroendocrine tumors, including those with lymph no…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Dual-Tracer Theranostic PET [NA]
Clinical trial update on dual-tracer theranostic PET imaging for neuroendocrine tumors and prostate cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Cabozantinib and Nivolumab for Carcinoid Tumors [Phase 2]
A Phase 2 study evaluating the combination of cabozantinib and nivolumab for carcinoid tumors has completed with results posted in January 2…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Olaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform to Small Cell Lung Cancer (SCLC) and Other Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating Olaparib plus Durvalumab in EGFR-mutated non-small cell lung cancer that transformed to small cell lung cancer an…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. [Phase 2]
This is a phase 2 trial evaluating the combination of platinum-doublet chemotherapy with nivolumab for gastroenteropancreatic neuroendocrine…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors [Phase 1, Phase 2]
The document reports a completed Phase 1/Phase 2 trial evaluating Lutetium-177 dotatate in combination with metronomic capecitabine for aggr…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver [Phase 2]
Phase 2 randomized trial evaluating embolization for liver metastases from malignant neuroendocrine tumors has completed enrollment; the stu…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Avelumab in G2-3 NET [Phase 2]
A Phase 2 trial of avelumab in patients with grade 2-3 neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting
A completed UK patient-preference study evaluated Somatuline Autogel (lanreotide) and treatment administration settings for neuroendocrine t…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients [Phase 2]
This Phase 2 clinical trial compares dosimetry-guided PRRT using Lu-177-DOTATOC to standard-dose PRRT in neuroendocrine neoplasm patients. T…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Phase 2 Study of ONC201 in Neuroendocrine Tumors [Phase 2]
Phase 2 study of ONC201 in recurrent or metastatic neuroendocrine tumors has completed enrollment with results posted on 2024-11-26.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors [Phase 3]
Phase 3 trial evaluating cabozantinib in advanced pancreatic neuroendocrine and carcinoid tumors; ACTIVE_NOT_RECRUITING with results posted …
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective [EARLY_Phase 1]
An early-phase trial evaluates how 68Ga-DOTATATE PET/CT impacts clinical management of neuroendocrine tumors from the referring physicians' …
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma [Phase 4]
Phase 4 trial evaluating liposomal irinotecan for neuroendocrine tumors. The study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
This clinical trial update reports the completion of studies examining biomarkers of angiogenesis in renal cell carcinoma and neuroendocrine…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor [NA]
The DIVIT study, a trial evaluating diet and vitamin supplementation in patients with neuroendocrine tumors, has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: 5-HIAA in Urine Versus 5-HIAA in Plasma Patients With a Serotonin Producing Neuroendocrine Tumor'
This completed clinical trial evaluated 5-HIAA levels in urine versus plasma in patients with serotonin-producing neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Optimal Feeding for NET Patients [NA]
A completed clinical trial evaluating optimal feeding strategies for patients with neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor [NA]
This entry notes the completion of a clinical trial evaluating a web-based tailored information and support program for patients with neuroe…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor: a Randomized Pilot Study [NA]
A randomized pilot study assessing a web-based tailored information and support program for patients with neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors [Phase 2]
Phase II trial of pembrolizumab plus lenvatinib in advanced well-differentiated neuroendocrine tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres [Phase 2]
Phase 2 trial investigating lanreotide in metastatic gastrointestinal neuroendocrine tumors undergoing liver-directed radioembolization.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Neoadjuvant PRRT With 177Lu-DOTATATE Followed by Surgery for Resectable PanNET [Phase 2]
Phase 2 trial update on neoadjuvant PRRT with 177Lu-DOTATATE followed by surgery for resectable pancreatic neuroendocrine tumors (PanNET).
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Phase III Study of Surufatinib in Treating Advanced Pancreatic Neuroendocrine Tumors [Phase 3]
Phase III study results for surufatinib in advanced pancreatic neuroendocrine tumors completed.
-
CLINICAL_TRIALS trial_result · 2022-12-22Clinical Trial Update: Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE [Phase 3]
Phase 3 trial assessing Cu64-DOTATATE imaging in patients with known or suspected somatostatin receptor–positive neuroendocrine tumors has c…